Skip to Content

635 Results Found

  • Review
  • Open Access
58 Citations
9,690 Views
12 Pages

Botulinum toxin A for the Treatment of Overactive Bladder

  • Po-Fan Hsieh,
  • Hung-Chieh Chiu,
  • Kuan-Chieh Chen,
  • Chao-Hsiang Chang and
  • Eric Chieh-Lung Chou

29 February 2016

The standard treatment for overactive bladder starts with patient education and behavior therapies, followed by antimuscarinic agents. For patients with urgency urinary incontinence refractory to antimuscarinic therapy, currently both American Urolog...

(This article belongs to the Special Issue Botulinum Toxin A on Lower Urinary Tract Dysfunction)
  • Review
  • Open Access
3,419 Views
12 Pages

Overactive Bladder: Where We Are and Where We Are Going

  • Charan S. Mohan,
  • Wai Lee and
  • Kathleen C. Kobashi

10 September 2021

Overactive bladder (OAB) is a heterogeneous syndrome estimated to affect approximately 10% to 15% of men and women globally. OAB not only negatively impacts quality of life but also results in a significant financial burden to both patients and healt...

  • Systematic Review
  • Open Access
9 Citations
4,624 Views
8 Pages

Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review

  • Antonio Cicione,
  • Riccardo Lombardo,
  • Vincenzo Umbaca,
  • Giorgia Tema and ,
  • Giacomo Gallo,
  • Jordi Stira,
  • Carmen Gravina,
  • Beatrice Turchi,
  • Antonio Franco and
  • Cosimo De Nunzio
  • + 9 authors+ 4 authors

4 January 2023

The aim of our study is to review the current available knowledge regarding preferences and expectations of patients with overactive bladder (OAB). The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement guidelines w...

(This article belongs to the Special Issue Latest Advances in Urinary Incontinence)
  • Article
  • Open Access
6 Citations
8,040 Views
12 Pages

Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological Patients

  • Artur Rogowski,
  • Maria Krowicka-Wasyl,
  • Ewa Chotkowska,
  • Tomasz Kluz and ,
  • Andrzej Wróbel,
  • Dominika Berent,
  • Paweł Mierzejewski,
  • Halina Sienkiewicz-Jarosz,
  • Adam Wichniak and
  • Przemyslaw Bienkowski
  • + 8 authors+ 3 authors

3 September 2021

Introduction and hypothesis: A link between psychiatric comorbidities and overactive bladder symptomatology has been suggested by preclinical and clinical studies. Given this, we hypothesized that a psychiatric history and current treatment with psyc...

(This article belongs to the Special Issue Current Trends in Urogynecology)
  • Article
  • Open Access
14 Citations
3,530 Views
10 Pages

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements

  • Aida Javan Balegh Marand,
  • Cléo Baars,
  • John Heesakkers,
  • Ellen van den Munckhof and ,
  • Morteza Ghojazadeh,
  • Mohammad Sajjad Rahnama’i and
  • Dick Janssen
  • + 2 authors+ 0 author

17 May 2023

Introduction: It has been hypothesized that the urinary microbiome might play an important role in OAB. Studies have been conducted on the association between OAB symptoms and the microbiome, although a possible causality still has to be determined....

(This article belongs to the Section Microbiology)
  • Article
  • Open Access
5 Citations
3,024 Views
26 Pages

The GPR39 Receptor Plays an Important Role in the Pathogenesis of Overactive Bladder and Corticosterone-Induced Depression

  • Jan Wróbel,
  • Paulina Iwaniak,
  • Piotr Dobrowolski,
  • Mirosława Chwil and ,
  • Ilona Sadok,
  • Tomasz Kluz,
  • Artur Wdowiak,
  • Iwona Bojar,
  • Ewa Poleszak and
  • Andrzej Wróbel
  • + 8 authors+ 3 authors

25 November 2024

Despite the close and clinically confirmed association between depression and overactive bladder, it remains unclear whether this affective disorder is a factor causing overactive bladder or whether overactive bladder is a specific symptom of psychos...

(This article belongs to the Special Issue Primary and Secondary Bladder Disorders in Neurourology and Inflammatory Diseases)
  • Article
  • Open Access
6 Citations
3,028 Views
10 Pages

Characteristics of the Urinary Proteome in Women with Overactive Bladder Syndrome: A Case-Control Study

  • Marianne Koch,
  • Pavel Lyatoshinsky,
  • Goran Mitulovic,
  • Barbara Bodner-Adler and ,
  • Sören Lange,
  • Engelbert Hanzal and
  • Wolfgang Umek
  • + 2 authors+ 0 author

31 May 2021

Despite an estimated prevalence of 13% in women, the exact etiology of non-neurogenic overactive bladder syndrome is unclear. The aim of our study was to gain a better understanding of the pathophysiology of female overactive bladder syndrome by mapp...

(This article belongs to the Special Issue Clinical Researches on Urogynaecology)
  • Article
  • Open Access
5 Citations
3,466 Views
15 Pages

The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms

  • Paulina Iwaniak,
  • Piotr Dobrowolski,
  • Jan Wróbel,
  • Tomasz Kluz and ,
  • Artur Wdowiak,
  • Iwona Bojar,
  • Klaudia Stangel-Wójcikiewicz,
  • Ewa Poleszak,
  • Artur Jakimiuk and
  • Andrzej Wróbel
  • + 7 authors+ 2 authors

31 October 2023

Overactive bladder syndrome (OAB) is a prevalent condition that affects the elderly population in particular and significantly impairs quality of life. Imperatorin, a naturally occurring furocoumarin, possesses diverse pharmacological properties that...

(This article belongs to the Special Issue Pathophysiology and Therapy of Bladder Function Disorders and Cystitis)
  • Article
  • Open Access
7 Citations
4,975 Views
8 Pages

Overactive Bladder during Pregnancy: A Prospective Longitudinal Study

  • Hung-Ju Chen,
  • Sheng-Mou Hsiao,
  • Cheng-Fang Yang,
  • Chien-Nan Lee and ,
  • Yi-Wen Wang,
  • Da-Wei Guo and
  • Shiow-Ru Chang
  • + 2 authors+ 0 author

6 February 2022

Background and Objectives: Overactive bladder (OAB) is a serious urination-related symptom of unknown pathogenesis that affects one’s everyday activities. The objective of this study was to examine how OAB prevalence, symptom severity, and degr...

  • Review
  • Open Access
35 Citations
5,673 Views
9 Pages

16 March 2020

Diabetes mellitus (DM) is an independent risk factor for overactive bladder (OAB). The pathophysiology of DM-associated OAB is multifactorial and time-dependent. Diabetic bladder dysfunction is highly associated with diabetic complications, mainly in...

(This article belongs to the Special Issue Botulinum Toxin Treatment for Pain and Inflammation in Functional Urological Disorders)
  • Review
  • Open Access
93 Citations
7,425 Views
12 Pages

Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies

  • Lin-Nei Hsu,
  • Ju-Chuan Hu,
  • Po-Yen Chen,
  • Wei-Chia Lee and
  • Yao-Chi Chuang

Metabolic syndrome (MetS) is defined by a group of cardiovascular risk factors, including impaired glucose tolerance, central obesity, hypertension, and dyslipidemia. Overactive bladder (OAB) syndrome consists of symptoms such as urinary urgency, fre...

(This article belongs to the Special Issue Bladder Dysfunction: From Molecular Pathology to Therapeutic Approaches)
  • Systematic Review
  • Open Access
12 Citations
4,296 Views
21 Pages

5 August 2024

Despite the efficacy of onabotulinumtoxinA, its safety profile remains a concern. This meta-analysis reviewed the major adverse events (AEs) associated with intravesical onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity (...

(This article belongs to the Special Issue Botulinum Toxin for Urinary Tract Disease: After a Decade from Approval)
  • Article
  • Open Access
2 Citations
1,224 Views
13 Pages

Background/Objectives: Overactive bladder (OAB), common in elderly women, involves urgency, frequency, and nocturia, with complex phenotypes. The use of neurotrophins as non-invasive urinary biomarkers has been previously explored. The objective of t...

(This article belongs to the Section Endocrinology and Clinical Metabolic Research)
  • Article
  • Open Access
11 Citations
3,099 Views
14 Pages

14 July 2022

This cross-sectional survey study evaluated associations between physician–patient communication and patient satisfaction with overactive bladder (OAB) medical care or clinical effectiveness. Japanese patients aged ≥50 years with OAB who had...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
6 Citations
3,221 Views
10 Pages

13 April 2021

Overactive Bladder (OAB) is a common condition that is known to have a significant impact on daily activities and quality of life. The pathophysiology of OAB is not completely understood. One of the new hypothetical causative factors of OAB is dysbio...

(This article belongs to the Special Issue Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice)
  • Article
  • Open Access
2,051 Views
11 Pages

The Efficacy of Intradetrusor Onabotulinumtoxin A Injection for Refractory Overactive Bladder Syndrome—A Single-Center Prospective Study

  • Chie Nakai,
  • Kosei Miwa,
  • Yasuhide Kitagawa,
  • Moemi Kikuchi and ,
  • Sanae Namiki,
  • Mina Kikuchi,
  • Kota Kawase,
  • Koji Iinuma,
  • Yuki Tobisawa and
  • Takuya Koie
  • + 6 authors+ 1 author

11 June 2025

Background/Objectives: Intradetrusor botulinum toxin injection is a well-established third-line therapy for patients with refractory overactive bladder (OAB) and detrusor overactivity (DO). Botulinum toxin type A (BoNT-A) is most commonly used due to...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
5 Citations
8,687 Views
14 Pages

Physical Agent-Based Treatments for Overactive Bladder: A Review

  • Nurida Khasanah,
  • Hung-Yen Chin and
  • Chih-Wei Peng

31 August 2022

Almost one-fifth of the people in the world experience a decrease in quality of life due to overactive bladder (OAB) syndrome. The main bothersome symptoms are urgency accompanied by urinary frequency and nocturia. This chronic, disabling condition i...

(This article belongs to the Special Issue Latest Advances in Urinary Incontinence)
  • Article
  • Open Access
7 Citations
4,335 Views
9 Pages

20 December 2021

We conducted a phase IV, pre/post multi-center study to evaluate the efficacy and safety of intradetrusor onabotulinumtoxinA injection in patients with neurogenic detrusor overactivity (NDO, n = 119) or overactive bladder (OAB, n = 215). Patients rec...

(This article belongs to the Special Issue Botulinum Toxins: Old and New Applications in Humans and Animals for the Treatment of Lower Urinary Tract Conditions)
  • Article
  • Open Access
1 Citations
2,684 Views
14 Pages

The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model

  • Jan Wróbel,
  • Łukasz Zapała,
  • Grzegorz Niemczyk,
  • Ewa Poleszak and ,
  • Piotr Dobrowolski,
  • Tomasz Kluz,
  • Anna Bogaczyk,
  • Patryk Jasielski,
  • Artur Wdowiak and
  • Andrzej Wróbel
  • + 7 authors+ 2 authors

29 January 2025

We aimed to determine whether berbamine (BBM) would have an effect on retinyl acetate (RA)-induced cystometric and biochemical parameters, characteristic of bladder overactivity. BBM exhibits anti-inflammatory, anti-oxidant, and muscle-relaxant effec...

(This article belongs to the Section Natural and Bio-derived Molecules)
  • Article
  • Open Access
1 Citations
1,893 Views
15 Pages

The Impact of Patient Navigators on Overactive Bladder Care: Real-World Practice Patterns from a US National Database

  • Ekene Enemchukwu,
  • Jennifer Miles-Thomas,
  • Nitya Abraham,
  • Diane K. Newman and ,
  • Marc Schwartz,
  • Kimberly Becker Ifantides,
  • Mariana Nelson and
  • Raveen Syan
  • + 3 authors+ 0 author

Background/Objectives: We here describe the impact of navigated care on utilization patterns of pharmacologic and minimally invasive overactive bladder therapies. Methods: This retrospective observational cohort study used electronic medical record d...

  • Article
  • Open Access
3 Citations
3,281 Views
14 Pages

15 May 2023

This study aimed to evaluate the treatment patterns and long-term efficacy of onabotulinumtoxinA injections in a clinical setting. This single-center retrospective study was conducted on patients with refractory overactive bladder (OAB) aged 18 years...

(This article belongs to the Special Issue Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? II)
  • Article
  • Open Access
5 Citations
3,198 Views
9 Pages

Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity

  • Maurizio Serati,
  • Maria Rosaria Campitiello,
  • Marco Torella,
  • Giada Mesiano and ,
  • Chiara Scancarello,
  • Fabio Ghezzi,
  • Andrea Papadia,
  • Elena Gamarra,
  • Giorgio Caccia and
  • Andrea Braga
  • + 5 authors+ 0 author

28 September 2024

Background: Mixed urinary incontinence (MUI) has always represented a major therapeutic challenge and the management of this type of incontinence is often complicated by uncertain outcomes. Surgical options include interventions targeting both stress...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1 Citations
3,579 Views
12 Pages

Prevalence of Urinary Incontinence and Overactive Bladder Among Female University Students in Kazakhstan

  • Yerzhan Sharapatov,
  • Aluadin Nurberdiev,
  • Nurbol Keulimzhayev,
  • Aigul Botabayeva and ,
  • Medet Toleubayev,
  • Mariya Dmitriyeva and
  • Rano Zhankina
  • + 2 authors+ 0 author

Background/Objectives: The aim of this research is to study the prevalence of urinary incontinence (UI) and overactive bladder (OAB) among female university students in Kazakhstan and to analyze the risk factors associated with these conditions. Meth...

  • Article
  • Open Access
39 Citations
7,056 Views
15 Pages

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder

  • Rajan Rajabalaya,
  • Guok Leen,
  • Jestin Chellian,
  • Srikumar Chakravarthi and
  • Sheba R. David

The goal of this study was to formulate and evaluate side effects of transdermal delivery of proniosomal gel compared to oral tolterodine tartrate (TT) for the treatment of overactive bladder (OAB). Proniosomal gels are surfactants, lipids and soy le...

  • Review
  • Open Access
22 Citations
10,700 Views
20 Pages

Drug Delivery Approaches for Managing Overactive Bladder (OAB): A Systematic Review

  • Zara Khizer,
  • Amina Sadia,
  • Raman Sharma,
  • Samia Farhaj and ,
  • Jorabar Singh Nirwan,
  • Pratibha G. Kakadia,
  • Talib Hussain,
  • Abid Mehmood Yousaf,
  • Yasser Shahzad and
  • Muhammad Usman Ghori
  • + 6 authors+ 1 author

26 April 2021

Overactive bladder syndrome (OAB) is characterised by urgency symptoms, with or without urgency incontinence, usually with frequency and nocturia and severely affects the quality of life. This systematic review evaluates the various drug delivery str...

(This article belongs to the Section Pharmaceutical Technology)
  • Article
  • Open Access
15 Citations
7,391 Views
13 Pages

Low Intensity Extracorporeal Shock Wave Therapy as a Potential Treatment for Overactive Bladder Syndrome

  • Jian-He Lu,
  • Kuang-Shun Chueh,
  • Shu-Mien Chuang,
  • Yi-Hsuan Wu and ,
  • Kun-Ling Lin,
  • Cheng-Yu Long,
  • Yung-Chin Lee,
  • Mei-Chen Shen,
  • Ting-Wei Sun and
  • Yung-Shun Juan
  • + 5 authors+ 0 author

16 June 2021

Background: The present study attempted to investigate the therapeutic effect and duration of low intensity extracorporeal shock wave therapy (LiESWT) on overactive bladder (OAB) symptoms, including social activity and the quality of life (QoL). Meth...

  • Article
  • Open Access
15 Citations
2,892 Views
19 Pages

Abnormal Resting-State Network Presence in Females with Overactive Bladder

  • Ulrich Mehnert,
  • Matthias Walter,
  • Lorenz Leitner,
  • Thomas M. Kessler and ,
  • Patrick Freund,
  • Martina D. Liechti and
  • Lars Michels
  • + 2 authors+ 0 author

Overactive bladder (OAB) is a global problem reducing the quality of life of patients and increasing the costs of any healthcare system. The etiology of OAB is understudied but likely involves supraspinal network alterations. Here, we characterized s...

(This article belongs to the Special Issue Bench to Bedside in Neuro-Urology)
  • Article
  • Open Access
15 Citations
7,155 Views
8 Pages

27 June 2021

Overactive bladder (OAB) is defined as urgency, usually with frequency, nocturia, and incontinence. Patients with liver cirrhosis often present with urinary complaints. The possible reason for this is fluid redistribution, which may induce OAB result...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1,735 Views
12 Pages

The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation

  • Kürşat Küçüker,
  • Hülya Aybek,
  • Hakan Akça,
  • Ege Rıza Karagür and ,
  • Elif Fırat,
  • Yusuf Özlülerden,
  • Sinan Çelen and
  • Zafer Aybek
  • + 3 authors+ 0 author

8 March 2025

Background and Objectives: This study aimed to determine the relationship between miRNAs and overactive bladder (OAB). We also aimed to reveal the diagnostic properties of miRNAs and their potential to predict responses to therapy. Materials and Meth...

(This article belongs to the Special Issue New Advances in Urology and Nephrology Disease: From Diagnosis to Treatment—2nd Edition)
  • Perspective
  • Open Access
5 Citations
5,010 Views
13 Pages

Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA

  • Karyn S. Eilber,
  • Benjamin M. Brucker,
  • Andrea Pezzella,
  • Vincent Lucente and ,
  • Kevin Benson and
  • Michael J. Kennelly
  • + 1 author+ 0 author

21 April 2025

OnabotulinumtoxinA is an FDA-approved treatment for adults with overactive bladder (OAB) who have an inadequate response to, or are intolerant of, oral pharmacotherapies including anticholinergics or beta-3 agonists. However, procedural practices of...

(This article belongs to the Special Issue Botulinum Toxin for Urinary Tract Disease: After a Decade from Approval)
  • Article
  • Open Access
16 Citations
5,680 Views
8 Pages

4 March 2022

Background and Objectives: The living environment can manifest physiological responses in humans, with cohabiting couples often having similar health statuses. The aim of this study was to (1) examine the prevalence of the overactive bladder (OAB) wi...

  • Article
  • Open Access
231 Views
12 Pages

Treatment Trajectories and Symptom Burden in Overactive Bladder: Long-Term Follow-Up of a Prospective, Nonrandomized Cohort

  • Adam Ostrowski,
  • Magdalena Ostrowska,
  • Filip Kowalski,
  • Maciej Dąbkowski and ,
  • Layla Settaf-Cherif,
  • Jan Mateusz Kiersztyn,
  • Tomasz A. Drewa,
  • Kajetan Juszczak,
  • Maciej J. Wróbel and
  • Jan Adamowicz
  • + 5 authors+ 0 author

27 October 2026

Background: Long-term overactive bladder (OAB) care involves treatment changes that are not captured by initial-prescription persistence alone. We examined treatment pathways, symptom burden, and xerostomia. Methods: This prospective nonrandomized co...

  • Article
  • Open Access
1 Citations
2,038 Views
10 Pages

Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy

  • Miguel Virseda-Chamorro,
  • Carlos Téllez,
  • Jesus Salinas-Casado,
  • Juliusz Szczesniewski and ,
  • Sonia Ruiz-Grana,
  • Ignacio Arance and
  • Javier C. Angulo
  • + 2 authors+ 0 author

5 December 2023

We aimed to determine the risk factors for postoperative overactive bladder (OAB) in patients treated with an adjustable trans-obturator male system (ATOMS) for stress incontinence after radical treatment of prostate cancer. A prospective study was p...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
3 Citations
3,306 Views
11 Pages

Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists

  • Mateusz Małkowski,
  • Agnieszka Almgren-Rachtan,
  • Magdalena Olszanecka-Glinianowicz,
  • Jerzy Chudek and
  • Piotr Chłosta

16 January 2024

Solifenacin, a selective muscarinic receptor antagonist, is one of the best-tolerated and most effective medicines that relieve storage symptoms in patients with an overactive bladder (OAB). However, the persistence of solifenacin in daily clinical p...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
3 Citations
4,228 Views
7 Pages

Sexual Dysfunction in Patients with Overactive Bladder Syndrome Treated with Botulinum Toxin

  • Joanna Sondka-Migdalska,
  • Pawel Blaszczynski and
  • Zbigniew Jablonowski

1 October 2024

Introduction: Overactive bladder (OAB) is a syndrome of the lower urinary tract characterized by urinary urgency, frequency, and nocturia, with or without urgency urinary incontinence. OAB significantly impacts all aspects of life—social, psych...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1,822 Views
17 Pages

Abnormal Cerebral Perfusion and Functional Connectivity in Women with Overactive Bladder

  • Shichun Chen,
  • Zongpai Zhang,
  • Yakun Zhang,
  • Kenneth Wengler and ,
  • Steven Weissbart,
  • Weiying Dai,
  • Xiang He and
  • Justina Tam
  • + 3 authors+ 0 author

Background: Overactive bladder (OAB) has been linked to abnormal cerebral blood flow (CBF) and functional connectivity (FC). However, findings related to CBF and FC changes in OAB remain inconsistent across the literature. Methods: This feasibility s...

(This article belongs to the Special Issue Application of MRI in Brain Diseases)
  • Article
  • Open Access
5 Citations
3,371 Views
12 Pages

17 July 2021

This article aims to explore changes in urinary concentrations of selected neurotrophins in the course of TENS therapy in children with overactive bladder (OAB). A two-group open-label prospective study was conducted. The intervention group comprised...

(This article belongs to the Special Issue Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice)
  • Article
  • Open Access
1 Citations
2,007 Views
12 Pages

Association Between Endogenous Equol Production and the Onset of Overactive Bladder in Postmenopausal Women

  • Hiroyuki Honda,
  • Tomohiro Matsuo,
  • Hidenori Ito,
  • Shota Kakita and ,
  • Shintaro Mori,
  • Kyohei Araki,
  • Kensuke Mitsunari,
  • Kojiro Ohba,
  • Yasushi Mochizuki and
  • Ryoichi Imamura
  • + 5 authors+ 0 author

12 June 2025

Objectives: Equol, a gut-derived metabolite of soy isoflavones with estrogenic activity, may influence bladder aging. However, the association between overactive bladder (OAB), which is closely linked to bladder aging, and the estrogenic effects of e...

(This article belongs to the Topic Gynecological Endocrinology Updates)
  • Article
  • Open Access
4 Citations
3,144 Views
7 Pages

Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse

  • Katarzyna Jankiewicz,
  • Michał Bogusiewicz,
  • Łukasz Nowakowski,
  • Tomasz Rechberger and ,
  • Artur Rogowski and
  • Pawel Miotla
  • + 1 author+ 0 author

13 February 2022

(1) Background: Overactive bladder (OAB) symptoms are frequently present in women with pelvic organ prolapse (POP). Although urinary nerve growth factor (NGF) is a promising biomarker of OAB, little is known about its role in patients with OAB second...

(This article belongs to the Special Issue Current Trends in Urogynecology)
  • Brief Report
  • Open Access
6 Citations
4,182 Views
7 Pages

26 October 2023

Background: Overactive bladder (OAB) is a syndrome defined as urinary urgency, accompanied by increased frequency and nocturia with or without urge incontinence, in the absence of urinary tract infection or other obvious pathology. The standard thera...

(This article belongs to the Special Issue Current Trends in Urogynecology: Part II)
  • Article
  • Open Access
7 Citations
3,223 Views
9 Pages

31 March 2023

This study aimed to evaluate the efficacy of intravesical botulinum toxin A (BoNT-A) injections for the treatment of pediatric overactive bladder (OAB) by exploring the differential treatment outcomes in children with different OAB etiologies and tho...

(This article belongs to the Topic Clinical, Translational, Basic Researches, and Application of Bacterial Toxins on Bladder Diseases and Lower Urinary Tract Dysfunctions)
  • Article
  • Open Access
497 Views
15 Pages

Associations of Vaginal Pressure and Transversus Abdominis Muscle Thickness with Overactive Bladder in Women: A Cross-Sectional Study

  • Tomohiro Matsuo,
  • Junko Tajima,
  • Asato Otsubo,
  • Shota Kakita and ,
  • Kensuke Mitsunari,
  • Kojiro Ohba and
  • Ryoichi Imamura
  • + 2 authors+ 0 author

16 August 2026

Background and Objectives: Overactive bladder (OAB) has been associated with pelvic floor dysfunction, but the associations of vaginal pressure (VP) and transversus abdominis (TVA) thickness with OAB remain unclear. We examined these associations in...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
12 Citations
7,711 Views
8 Pages

Pre- versus Post-Menopausal Onset of Overactive Bladder and the Response to Vaginal Estrogen Therapy: A Prospective Study

  • Yoav Baruch,
  • Marco Torella,
  • Sarah De Bastiani,
  • Michele Meschia and ,
  • Massimo Candiani,
  • Nicola Colacurci and
  • Stefano Salvatore
  • + 2 authors+ 0 author

27 January 2023

Background and Objectives: This study examined the utility of local estrogen therapy for improving urinary symptoms in women diagnosed with Overactive Bladder allied to the time of onset of urinary symptoms whether pre- or post-menopausal. Materials ...

(This article belongs to the Special Issue New Insights and Perspectives in Minimally Invasive Gynecology)
  • Article
  • Open Access
769 Views
10 Pages

Background/Objectives: Percutaneous tibial nerve stimulation (PTNS) is a minimally invasive intervention for overactive bladder (OAB) typically utilized in patients for whom behavioural and pharmacological therapies do not work. The aim of this study...

  • Article
  • Open Access
10 Citations
4,249 Views
10 Pages

Impact of Mirabegron Administration on the Blood Pressure and Pulse Rate in Patients with Overactive Bladder

  • Hidenori Ito,
  • Tomohiro Matsuo,
  • Kensuke Mitsunari,
  • Kojiro Ohba and
  • Yasuyoshi Miyata

19 June 2022

Background and Objectives: To determine changes in the blood pressure (BP) and pulse rate (PR) before and after the administration of mirabegron in real-world clinical practice for patients with overactive bladder (OAB). Materials and Methods: This s...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
1 Citations
2,997 Views
9 Pages

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder

  • Laura M. Tellechea,
  • Samantha Freeman,
  • Ilir Agalliu,
  • Melissa A. Laudano and ,
  • Sylvia O. Suadicani and
  • Nitya Abraham
  • + 1 author+ 0 author

19 September 2022

Metabolomics analysis of urine before and after overactive bladder (OAB) treatment may demonstrate a unique molecular profile, allowing predictions of responses to treatment. This feasibility study aimed to correlate changes in urinary metabolome wit...

(This article belongs to the Special Issue Crosstalk between Metabolic Syndrome and Voiding Dysfunction)
  • Article
  • Open Access
9 Citations
4,207 Views
15 Pages

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome

  • Habiba Shabir,
  • Sana Hashemi,
  • Moussa Al-Rufayie,
  • Tayo Adelowo and ,
  • Umar Riaz,
  • Umayair Ullah,
  • Benyamin Alam,
  • Mehreen Anwar and
  • Laure de Preux
  • + 4 authors+ 0 author

Background: The UK National Health Service (NHS) propose the use of oxybutynin prior to onabotulinumtoxinA (Botox) in the management of overactive bladder syndrome (OAB). Oxybutynin is costly and associated with poor adherence, which may not occur wi...

(This article belongs to the Section Health Behavior, Chronic Disease and Health Promotion)
  • Article
  • Open Access
6 Citations
8,771 Views
17 Pages

Use of Fermented Red Clover Isoflavones in the Treatment of Overactive Bladder in Postmenopausal Women: A Randomized, Double-Blinded, Placebo-Controlled Trial

  • Annemarie B. Villadsen,
  • Julie N. Holm-Jacobsen,
  • Bala K. Prabhala,
  • Caspar Bundgaard-Nielsen and ,
  • Pam Huntjens,
  • Jette B. Kornum,
  • Karin Glavind,
  • Peter D. C. Leutscher,
  • Lars P. Christensen and
  • Louise T. S. Arenholt
  • + 7 authors+ 2 authors

27 September 2023

Postmenopausal women are at risk of developing an overactive bladder (OAB). Conventional vaginal estrogen has shown promise for symptom relief. Isoflavones have proven effective as an alternative to estrogen treatment against menopause-related sympto...

(This article belongs to the Special Issue Dietary Interventions and Women’s Health)
  • Article
  • Open Access
3,517 Views
14 Pages

A Dataset for Constructing the Network Pharmacology of Overactive Bladder and Its Application to Reveal the Potential Therapeutic Targets of Rhynchophylline

  • Yan Tie,
  • Jihan Liu,
  • Yushan Wu,
  • Yining Qiang and ,
  • Ge’Er Cai’Li,
  • Pingxiang Xu,
  • Ming Xue,
  • Liping Xu,
  • Xiaorong Li and
  • Xuelin Zhou
  • + 5 authors+ 0 author

24 September 2024

Objectives: Network pharmacology is essential for understanding the multi-target and multi-pathway therapeutic mechanisms of traditional Chinese medicine. This study aims to evaluate the influence of database quality on target identification and to e...

(This article belongs to the Section Natural Products)
  • Article
  • Open Access
5 Citations
3,190 Views
10 Pages

The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled Study

  • Yasufumi Ueda,
  • Tomohiro Matsuo,
  • Ken Kawada,
  • Hidenori Ito and ,
  • Kensuke Mitsunari,
  • Kojiro Ohba and
  • Ryoichi Imamura
  • + 2 authors+ 0 author

28 February 2023

Background and Objectives: To examine the relationship between the presence of earlobe crease (EC) and overactive bladder (OAB). Materials and Methods: The earlobes of the participants were examined macroscopically. ECs were further divided into four...

(This article belongs to the Topic Pathophysiology of Aging and Age-related Diseases)

of 13